Ossium Health Stock
HealthTechLooking to sell Ossium Health stock or options?
Ossium Health develops stem cell-based therapies aimed at enhancing human health, vitality, and longevity through bioengineering. These therapies target the cure of leukemia and other blood disorders, enhance organ transplantation outcomes, treat radiation poisoning, and facilitate tissue repair. By doing so, Ossium Health empowers healthcare professionals to significantly boost the well-being, vitality, and lifespan of individuals.
Elevate Ventures, First Round Capital, Asahi Kasei, Junchao Shangguan, Alumni Ventures, Manta Ray Ventures, Mike Kruzeniski, Gaingels, B Capital Group, Hemisphere Ventures, Mount Pleasant Ventures, National Institute of General Medical Sciences, Nikhil Agarwal, and Blood Institute, CPMG, National Heart, U.S. Department of Health and Human Services, Alex Felix, National Institute for Allergy and Infectious Disease, Maynd Jolly, General Catalyst, XYZ Venture Capital, Village Global, Lung, Wormhole Capital.